Compounds > valine

valine and Hemorrhagic Thrombocythemia

valine has been researched along with Hemorrhagic Thrombocythemia in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (47.37)29.6817
2010's10 (52.63)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Álvarez-Larrán, A; Angona, A; Bellosillo, B; Besses, C; Camacho, L; Fernández-Rodríguez, C; Longarón, R; Senín, A1
Chen, SS; Gale, RP; Huang, XJ; Jiang, B; Jiang, H; Jiang, Q; Li, JL; Li, LD; Li, N; Liu, KY; Ruan, GR; Shi, HX; Yao, QM; Zhao, XS1
Ambler, K; Casolari, DA; D'Andrea, RJ; Nguyen, T; Ross, DM; Tiong, IS; Van Velzen, MJ1
Cazzola, M; Rumi, E1
Ziakas, PD1
Antonioli, E; Barosi, G; Bosi, A; Guglielmelli, P; Pieri, L; Vannucchi, AM1
Passamonti, F; Rumi, E1
Tefferi, A1
Baccarani, M; Catani, L; Fiacchini, M; Martinelli, G; Ottaviani, E; Palandri, F; Polverelli, N; Salmi, F; Vianelli, N1
Choi, SI; Kim, HS; Kwak, JY; Lee, NR; Sohn, JY; Song, EK; Song, MJ; Yhim, HY; Yim, CY1
Hsiao, HH; Hsu, JF; Lee, CP; Lin, SF; Liu, YC; Tsai, HJ1
Dal Cin, P; Hernandez, JM; Kuo, FC; Leon, A; Longtine, JA; Staropoli, JF1
Ameye, G; Constantinescu, SN; Demoulin, JB; Duhoux, FP; Herman, M; Iossifidis, S; Lambert, C; Libouton, JM; Poirel, HA1
Iványi, JL; Marton, E; Plander, M1
Álvarez-Larrán, A; Angona, A; Bellosillo, B; Besses, C; Florensa, L; Longarón, R; Martínez-Avilés, L; Navarro, G; Pedro, C; Serrano, S; Torres, E1
Baxter, EJ; Campbell, PJ; Culligan, DA; Fourouclas, N; Green, AR; Huntly, BJ; Li, J; Munro, LR; Roberts, I; Scott, LM; Swanton, S; Vassiliou, GS1
Au, WY; Fung, A; Kwong, YL; Lam, CC; Lam, KY; Lie, AK1
Dirnhofer, S; Hao-Shen, H; Looser, R; Schwaller, J; Skoda, RC; Sobas, MA; Tiedt, R1
Fujimoto, H; Gotoh, A; Ito, Y; Kiguchi, T; Kimura, Y; Miyazawa, K; Ohyashiki, JH; Ohyashiki, K; Tauchi, T1

Other Studies

19 other study(ies) available for valine and Hemorrhagic Thrombocythemia

ArticleYear
Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up.
    Annals of hematology, 2018, Volume: 97, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Cell Transformation, Neoplastic; Cytogenetic Analysis; Disease Progression; Female; Follow-Up Studies; Gene Frequency; Humans; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Phenylalanine; Polycythemia Vera; Thrombocythemia, Essential; Valine

2018
Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.
    Leukemia research, 2015, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Amino Acid Substitution; Asian People; Base Sequence; Calreticulin; Female; Gene Frequency; Genotype; Humans; Janus Kinase 2; Male; Middle Aged; Molecular Sequence Data; Mutation; Phenylalanine; Primary Myelofibrosis; Receptors, Thrombopoietin; Thrombocythemia, Essential; Valine; Young Adult

2015
Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera.
    Blood cancer journal, 2016, 08-19, Volume: 6, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Asymptomatic Diseases; Cohort Studies; Disease Progression; Female; Genetic Predisposition to Disease; Humans; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Phenylalanine; Polycythemia Vera; Polymorphism, Single Nucleotide; Prodromal Symptoms; Thrombocythemia, Essential; Valine

2016
How I treat essential thrombocythemia.
    Blood, 2016, 11-17, Volume: 128, Issue:20

    Topics: Adult; Aged; Amino Acid Substitution; Clinical Decision-Making; Diagnosis, Differential; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Phenylalanine; Thrombocythemia, Essential; Valine; Young Adult

2016
Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.
    Haematologica, 2008, Volume: 93, Issue:9

    Topics: Humans; Janus Kinase 2; Phenylalanine; Risk Factors; Thrombocythemia, Essential; Thrombocytosis; Thrombosis; Uncertainty; Valine

2008
JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis.
    Haematologica, 2009, Volume: 94, Issue:1

    Topics: Adult; Aged; Alleles; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Phenotype; Polycythemia Vera; Prognosis; Thrombocythemia, Essential; Valine

2009
Clinical relevance of JAK2 (V617F) mutant allele burden.
    Haematologica, 2009, Volume: 94, Issue:1

    Topics: Alleles; Female; Humans; Janus Kinase 2; Male; Mutation; Pedigree; Phenotype; Phenylalanine; Thrombocythemia, Essential; Valine

2009
JAK2V617F: more than a clonal marker?
    Leukemia & lymphoma, 2009, Volume: 50, Issue:2

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Humans; Janus Kinase 2; Mutation; Prognosis; Thrombocythemia, Essential; Valine

2009
JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cohort Studies; Female; Follow-Up Studies; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Thrombocythemia, Essential; Time Factors; Treatment Outcome; Valine

2009
JAK2 V617F-positive essential thrombocythemia in a patient with Klinefelter syndrome: a case report.
    Cancer genetics and cytogenetics, 2010, Apr-15, Volume: 198, Issue:2

    Topics: Adult; Amino Acid Substitution; Chromosome Banding; Humans; Janus Kinase 2; Klinefelter Syndrome; Male; Mutation, Missense; Phenylalanine; Thrombocythemia, Essential; Valine

2010
JAK2V617F mutation is associated with special alleles in essential thrombocythemia.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:3

    Topics: Alleles; Amino Acid Substitution; DNA Mutational Analysis; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Humans; Janus Kinase 2; Leucine; Lysine; Mutation, Missense; Phenylalanine; Polymorphism, Single Nucleotide; Receptors, Thrombopoietin; Thrombocythemia, Essential; Tryptophan; Valine

2011
Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.
    Leukemia research, 2011, Volume: 35, Issue:9

    Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Chromosome Aberrations; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 9; Cohort Studies; Disease Progression; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Phenylalanine; Recurrence; Thrombocythemia, Essential; Translocation, Genetic; Valine

2011
Novel head-to-head gene fusion of MLL with ZC3H13 in a JAK2 V617F-positive patient with essential thrombocythemia without blast cells.
    Leukemia research, 2012, Volume: 36, Issue:1

    Topics: Aged, 80 and over; Amino Acid Substitution; Base Sequence; Blast Crisis; Cell Cycle Proteins; Gene Fusion; Histone-Lysine N-Methyltransferase; Humans; Janus Kinase 2; Male; Myeloid-Lymphoid Leukemia Protein; Nuclear Proteins; Phenylalanine; Polymorphism, Single Nucleotide; RNA-Binding Proteins; Sequence Inversion; Thrombocythemia, Essential; Valine

2012
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Orvosi hetilap, 2011, Nov-06, Volume: 152, Issue:45

    Topics: Adult; Aged; Bone Marrow Neoplasms; Chronic Disease; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Phenylalanine; Polycythemia Vera; Polymerase Chain Reaction; Predictive Value of Tests; Primary Myelofibrosis; Retrospective Studies; Signal Transduction; Thrombocythemia, Essential; Thrombosis; Valine

2011
Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia.
    Annals of hematology, 2012, Volume: 91, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Clone Cells; Cohort Studies; Female; Follow-Up Studies; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Phenylalanine; Thrombocythemia, Essential; Valine; Young Adult

2012
An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivation.
    Haematologica, 2006, Volume: 91, Issue:8

    Topics: Amino Acid Substitution; Base Sequence; Blotting, Southern; Bone Marrow; Breast Neoplasms; Chromosome Disorders; Chromosome Mapping; Chromosome Walking; Chromosomes, Human, Pair 5; Chromosomes, Human, X; DNA Methylation; DNA Primers; Female; Humans; Janus Kinase 2; Middle Aged; Phenylalanine; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sex Chromosome Disorders; Thrombocythemia, Essential; Translocation, Genetic; Valine

2006
Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.
    Annals of hematology, 2007, Volume: 86, Issue:2

    Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Janus Kinase 2; Leukemia; Male; Middle Aged; Mutation; Phenylalanine; Recurrence; Thrombocythemia, Essential; Treatment Failure; Valine

2007
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.
    Blood, 2008, Apr-15, Volume: 111, Issue:8

    Topics: Animals; Colony-Forming Units Assay; Granulocytes; Hematopoiesis, Extramedullary; Humans; Hyperplasia; Integrases; Janus Kinase 2; Megakaryocytes; Mice; Mice, Transgenic; Mutant Proteins; Myeloproliferative Disorders; Phenotype; Phenylalanine; Polycythemia Vera; Primary Myelofibrosis; Recombination, Genetic; Thrombocythemia, Essential; Transgenes; Valine

2008
Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.
    International journal of hematology, 2008, Volume: 87, Issue:4

    Topics: Aged; Female; Humans; Janus Kinase 2; Leukocytosis; Male; Middle Aged; Mutation; Phenylalanine; Thrombocythemia, Essential; Thrombosis; Valine

2008